Sulfobutyllether-β-cyclodeextrin pharmaceutical excipient est Cyclodextrin derivateanam et Sina Deli scriptor novum genus pharmaceutical excipients.
Sulfobutylether, β-cyclodExtrin pharmaceutical excipient
CAS: 182410-00-0
Specie Alba pulveris, dulcis, insipidus et innocua
Fascel vitae, XXXVI mensibus
Grade, iniectio gradu
Application: Pharmaceuticals Feild
Latin: USP, Album
Solubility: ≥100 (XXV ℃, G / 100ml)
Gravis Metal: ≤0.0025%
Reducing Sugars: ≤0.05%
Product Description
Sulfobutylether-β-cyclodeextrin pharmaceutical excipient non solum potest augere medicamento solubility, amplio stabilitatem et salus de medicamento, quod potest reducere ad stilities ad iniectio situm administrationis, quod potest reducere in excitanda ad sanguinem concentration requiritur, paratum tempus medicamento actio.
Inranasal medicamento habens celeri effusio, ieiunium agens, princeps bioavailability, convenient administrationem, facile accipere aegris, et vitare iecoris primis transiet effectum et aliis commoda, quae in hotspots in pharmaceutical investigationes. Tamen, ex humilis penetratio nasi medicinae, multis enzymes in nasi cavitatis potest facere degradation et nasi adhaesionem.
Sulfobutylether-β-cyclodeextrin pharmaceutical excipient est sodium sal produci cum tribuitur, cum Porphyrio est alkaline per 1,4-butanesulfonic acidum lactone sub alkaline conditionibus. Est anion, altus aquam, solutum Retadex inde. Sulfobutyllether-β-CyclodExtrin pharmaceutical excipient potest esse bene combined cum medicamento moleculis ad formare non-covalent ita crebro stabilitatem, aquam solubility, et salus medicamento, reducendo eius renum, et salus rate, covering malum, etc.
